Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Madrigal Pharmaceuticals (MDGL) over the last 5 years, with Q3 2025 value amounting to 15.3.

  • Madrigal Pharmaceuticals' Interest Coverage Ratio rose 5161.28% to 15.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 17.56, marking a year-over-year increase of 5147.91%. This contributed to the annual value of 33.94 for FY2024, which is 1337.69% down from last year.
  • As of Q3 2025, Madrigal Pharmaceuticals' Interest Coverage Ratio stood at 15.3, which was up 5161.28% from 14.46 recorded in Q2 2025.
  • Madrigal Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 14.46 for Q2 2025, and its period low was 90.09 during Q2 2022.
  • Moreover, its 4-year median value for Interest Coverage Ratio was 30.71 (2023), whereas its average is 36.0.
  • In the last 5 years, Madrigal Pharmaceuticals' Interest Coverage Ratio tumbled by 4918.62% in 2024 and then soared by 6747.15% in 2025.
  • Madrigal Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 50.71 in 2022, then skyrocketed by 41.81% to 29.51 in 2023, then soared by 35.11% to 19.15 in 2024, then increased by 20.11% to 15.3 in 2025.
  • Its Interest Coverage Ratio was 15.3 in Q3 2025, compared to 14.46 in Q2 2025 and 24.06 in Q1 2025.